Sometimes it is Not as Simple as Sepsis: An Unusual Cause of Coagulopathy.
作者信息
Shah Kunal, Hanlon Ashley, Onwuemene Oluwatoyosi A
机构信息
Duke University School of Medicine, Durham, NC.
Department of Medicine, Duke University Medical Center, Durham, NC.
出版信息
Am J Med. 2021 Jul;134(7):e409-e411. doi: 10.1016/j.amjmed.2020.12.020. Epub 2021 Jan 12.
Abstract
摘要
相似文献
1
Sometimes it is Not as Simple as Sepsis: An Unusual Cause of Coagulopathy.有时并非像脓毒症那么简单：凝血障碍的一个不寻常原因。
Am J Med. 2021 Jul;134(7):e409-e411. doi: 10.1016/j.amjmed.2020.12.020. Epub 2021 Jan 12.
2
The coagulopathy of trauma versus disseminated intravascular coagulation.创伤性凝血病与弥散性血管内凝血
J Trauma. 2006 Jun;60(6 Suppl):S12-9. doi: 10.1097/01.ta.0000199545.06536.22.
3
Coagulation disorders in septic shock.脓毒性休克中的凝血障碍。
Intensive Care Med. 1993;19 Suppl 1:S8-15. doi: 10.1007/BF01738944.
4
[Disseminated intravascular coagulation and circulatory shock].
Kardiologiia. 1982;22(7):39-44.
5
COVID-19-associated coagulopathy and disseminated intravascular coagulation.COVID-19 相关凝血功能障碍和弥散性血管内凝血。
Int J Hematol. 2021 Jan;113(1):45-57. doi: 10.1007/s12185-020-03029-y. Epub 2020 Nov 7.
6
Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation.脓毒症诱导的凝血病和弥散性血管内凝血
Anesthesiology. 2020 May;132(5):1238-1245. doi: 10.1097/ALN.0000000000003122.
7
[A new concept of DIC: SIRS-associated coagulopathy].[弥散性血管内凝血的新概念：全身炎症反应综合征相关凝血病]
Rinsho Byori. 2011 Feb;Suppl 147:13-9.
8
Complement activation and coagulopathy - an ominous duo in COVID19.补体激活与凝血障碍——COVID-19 中的凶险组合。
Expert Rev Hematol. 2021 Feb;14(2):155-173. doi: 10.1080/17474086.2021.1875813. Epub 2021 Jan 22.
9
[Intravascular blood coagulation and its role in malignant neoplasms].[血管内血液凝固及其在恶性肿瘤中的作用]
Vopr Onkol. 1981;27(7):96-103.
10
Blood clotting abnormalities in liver disease.肝病中的凝血异常。
Prog Liver Dis. 1976;5:350-62.
本文引用的文献
1
The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review.侵袭性肥大细胞增生症的范围：一个研讨会报告和文献回顾。
Pathobiology. 2020;87(1):2-19. doi: 10.1159/000504099. Epub 2019 Dec 4.
2
Novel approaches to treating advanced systemic mastocytosis.治疗晚期系统性肥大细胞增多症的新方法。
Clin Pharmacol. 2019 Jul 10;11:77-92. doi: 10.2147/CPAA.S206615. eCollection 2019.
3
Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.成人系统性肥大细胞增生症：诊断、危险分层和治疗的 2019 年更新。
Am J Hematol. 2019 Mar;94(3):363-377. doi: 10.1002/ajh.25371. Epub 2019 Jan 2.
4
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.肥大细胞增多症：2016年世界卫生组织更新分类及新出现的治疗理念。
Blood. 2017 Mar 16;129(11):1420-1427. doi: 10.1182/blood-2016-09-731893. Epub 2016 Dec 28.
5
A French National Survey on Clotting Disorders in Mastocytosis.一项关于肥大细胞增多症凝血障碍的法国全国性调查。
Medicine (Baltimore). 2015 Oct;94(40):e1414. doi: 10.1097/MD.0000000000001414.
6
Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder.肥大细胞增多症：一种由KIT受体突变诱导的骨髓增殖性疾病。
Oncotarget. 2015 Jul 30;6(21):18250-64. doi: 10.18632/oncotarget.4213.
7
Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation.局限于肥大细胞的四聚体形成类胰蛋白酶及其在止血和凝血中的有益作用。
Immunol Allergy Clin North Am. 2014 May;34(2):263-81. doi: 10.1016/j.iac.2014.01.001. Epub 2014 Mar 15.
8
The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.肥大细胞疾病调查：患者的体验和看法。
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):70-6. doi: 10.1016/j.jaip.2013.09.004. Epub 2013 Dec 3.
9
Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.活化部分凝血活酶时间和抗 Xa 测量在肝素监测中的应用：不相符的生化基础。
Am J Clin Pathol. 2013 Apr;139(4):450-6. doi: 10.1309/AJCPS6OW6DYNOGNH.
10
Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.一名患有系统性肥大细胞增多症的37岁女性因类肝素抗凝剂导致致命性出血。
Clin Appl Thromb Hemost. 2008 Jul;14(3):360-4. doi: 10.1177/1076029607309173. Epub 2007 Dec 26.
Zotero 插件